City of Hope conducts basic research that produces valuable intellectual property, which is translated into new products, new businesses and new jobs.
The Sylvia R. and Isador A. Deutch Center for Applied Technology Development (CATD) offers broad expertise in technology transfer and licensing, biologics manufacturing, quality assurance and regulatory affairs. It also fosters commercial investment in the development of inventions and discoveries derived from research at City of Hope by licensing the relevant intellectual property. Through evaluation, marketing and licensing processes, CATD supports this goal by ensuring that technologies created at City of Hope are developed and commercialized for the benefit of the widest possible audience.
Among its many activities, CATD also hosts conferences for venture capitalists, at which City of Hope investigators present their findings to potential funding sources.
Office of Technology Licensing (OTL)
actively pursues patent protection for new inventions devised by its investigators deemed of commercial importance. Further, the OTL licenses intellectual property (IP) via Internet marketing, targeted marketing and inquiries by outside interested parties.
Center for Biomedicine & Genetics (CBG)
is a premier academic facility specializing in rapid production of pharmaceutical-grade materials. CBG invites collaborators from other institutions and biopharmaceutical companies to test promising new therapeutics, and supports phase I and II clinical trials at City of Hope.
Partners and Contributors
City of Hope is deeply grateful to our partners whose contributions have made the
Center for Biomedicine & Genetics
possible. In particular, we would like to thank the
National Office Products Industry
. In recognition of their generous gift to CBG, the first floor of the CBG facility is named the Sylvia R. and Isador A. Deutch Center for Applied Technology Development.